UPCC 20222 Protocol to permit collection of circulating biomarkers in pancreatic cancer

Study on Circulating Biomarkers in Pancreatic Cancer

Enrolling By Invitation
18 years or above
All
Phase N/A
30 participants needed
1 Location

Brief description of study

This protocol will involve collection of blood samples from patients with a diagnosis of pancreatic adenocarcinoma for evaluation of circulating biomarkers.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Pancreas Cancer
  • Age: 18 years or above
  • Gender: All

Inclusion Criteria:

  • The subject must have a known or presumed diagnosis of pancreatic adenocarcinoma
  • The subject must be a patient of the University of Pennsylvania
  • The subject must be able to provide informed consent
  • The subject must be 18 years of age or older

Exclusion Criteria:

. Subjects who have any clinically significant psychiatric, social, or medical condition that, in the opinion of the investigator, could increase the patient's risk, interfere with protocol adherence, or affect the patient's ability to give informed consent are ineligible to participate in the study.

This study investigates circulating biomarkers in patients with pancreatic adenocarcinoma. The purpose of this study is to collect blood samples from patients to evaluate these biomarkers, which are substances that can be measured in the blood and may provide information about the cancer.

Participants will undergo a procedure to collect blood samples. The collection of these samples is necessary to study the biomarkers, which could help in understanding the disease better. The procedure involves drawing blood from the participants, which is a common medical practice.

  • Who can participate: Adults aged 18 or older with a known or presumed diagnosis of pancreatic adenocarcinoma who are patients at the University of Pennsylvania can participate. Participants must be able to provide informed consent.
  • Study details: Participants will have blood samples collected for the study. This involves a standard procedure of drawing blood, which is important for evaluating the circulating biomarkers related to pancreatic cancer.
Updated on 28 Jul 2026. Study ID: 22-1599
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Abramson Cancer Center Navigator